Cargando…
HDAC4 in ischemic stroke: mechanisms and therapeutic potential
Stroke is one of the leading causes of death and disability worldwide, and the majority of the cases are ischemic stroke. However, it still lacks effective treatment except for thrombolytic therapy in an extremely narrow time window. Increased evidence suggests that histone deacetylase 4 (HDAC4) was...
Autores principales: | Kong, Qingsheng, Hao, Yongnan, Li, Xin, Wang, Xin, Ji, Bingyuan, Wu, Yili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136233/ https://www.ncbi.nlm.nih.gov/pubmed/30208931 http://dx.doi.org/10.1186/s13148-018-0549-1 |
Ejemplares similares
-
Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
por: Wu, Yili, et al.
Publicado: (2017) -
Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target
por: Wu, Yili, et al.
Publicado: (2016) -
Tau as a potential therapeutic target for ischemic stroke
por: Chen, Xin, et al.
Publicado: (2019) -
AMPK: Potential Therapeutic Target for Ischemic Stroke
por: Jiang, Shuai, et al.
Publicado: (2018) -
Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
por: Tian, Yanjun, et al.
Publicado: (2019)